Multi-omics experiments allow researchers to make important discoveries in ways that have never before been possible. However, integrating these data into a broader biological context can be challenging and time consuming when using standard resources.
At QIAGEN, we have introduced an innovative solution to this challenge: The market-leading QIAGEN Ingenuity Pathway Analysis (IPA) software integrated with our QIAGEN OmicSoft databases.
In this webinar, Lynne Mullen, Ph.D., Senior Scientist, QIAGEN Digital Insights, will present a use case for QIAGEN IPA and QIAGEN OmicSoft in the analysis of changes in postnatal mouse heart tissues using transcriptomic, proteomic and metabolomic data. These topics will be discussed in this webinar:
Don’t miss this opportunity to learn how to improve the processing of multi-omics data!
Lynne Mullen is a Senior Scientist in QIAGEN Digital Insights’ Scientific and Technical support team. Lynne completed her Ph.D. at Harvard University and continued to teach at Harvard after receiving her doctorate. Before her time at Harvard, she spent several years as a research scientist at Cedars-Sinai Prostate Cancer Center and Quest Diagnostics. Lynne has many years of experience researching the genetic basis of human ophthalmic genetic disorders, working at the University of California at Los Angeles Department of Ophthalmology and the University of Florida Department of Ophthalmology. Lynne has received numerous awards and fellowships from the National Science Foundation, the American Society of Mammologists and other esteemed institutions.
Thank you for your interest in this webinar on multi-omic changes in the postnatal mouse heart identified by QIAGEN IPA and QIAGEN OmicSoft.
Please find the link to the recording in your email inbox or start watching the webinar now.
* Mandatory fields